{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T10:51:05Z","timestamp":1649155865084},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/mjt.0b013e318293b11b","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T14:21:31Z","timestamp":1372170091000},"page":"460-462","source":"Crossref","is-referenced-by-count":0,"title":["Progress in the Treatment of Peripheral T-Cell Lymphomas"],"prefix":"10.1097","volume":"20","author":[{"given":"Ronald","family":"Lieberman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210202","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":". International peripheral T-cell lymphoma and natural killerT-cell lymphoma study. Pathologic findings and clinical outcomes.","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"R3-2-20210202","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1182\/blood-2010-05-231548","article-title":". Peripheral T-cell lymphoma.","volume":"117","author":"Foss","year":"2011","journal-title":"Blood"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1200\/JCO.2010.29.9024","article-title":"Pinter-Brown, et al.. Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.","volume":"29","author":"OConnor","year":"2011","journal-title":"J Clin Oncol"},{"key":"R6-2-20210202","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2011.37.4223","article-title":". Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.","volume":"30","author":"Coiffier","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0b013e318293b11b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:38:00Z","timestamp":1620963480000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201309000-00002"}},"subtitle":["An Orphan No More"],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":4,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e318293b11b","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}